The Color of Our Genes
By Osagie Obasogie,
Science Progress
| 06. 15. 2009
Balancing the Promise and Risks of Racial Categories in Human Biotechnology
A group of faculty members from Stanford University recently published a set of guidelines for using race in human genetics research. These guidelines, called the “Ten Commandments of Race and Genetics” by the New Scientist, provide both a descriptive account of the relevance of race to biomedical research and normative suggestions that call for using racial categories in a responsible manner.
These recommendations come at a time when the race and genetics conversation is at a fever pitch. Many hope that advances in human biotechnology will yield profound medical, scientific, and social advances. But what often goes unacknowledged is that if we are not extremely careful, commercial and forensic applications utilizing human biotechnology may resuscitate harmful ideas about the significance of genetics to understanding racial difference and the cause of racial disparities. To help mitigate such misunderstandings, policy tools such as race impact assessments should be adopted widely across several regulatory agencies. By facilitating greater engagement between public policy and human biotechnology, race impact assessments can provide a forum for multiple stakeholders to work with government...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...